Proven MedTech Leader, Investor, Advisor
Jonathan Lehmann is a MedTech Leader, Angel, and Commercial Consultant. He is a 20-year veteran of the space and is driven by the purpose of playing a role in the funding and commercializing of minimally-invasive, clinically-effective, financially-viable, and patient-centric ideas that benefit patients, providers, and payers.
He has sold, built salesforces, funded, and forged strategic partnerships in numerous markets from primary care to endocrine to cardiology to psychiatry to genetics to population health to sports medicine to regenerative health. But his sweetspot markets are ENT and Urology where he created scalable in office procedural models that fueled explosive growth against J&J, AMS, Smith & Nephew, and Medtronic leading to immense value creation for providers and companies during two liquidity events ENTL Nasdaq $70m IPO & subsequent $662m sale to Stryker.
In his spare time you can find him on the water talking business, foiling, or sharing his love for and the beauty that is the "Blue Mindset".